Anti-SARS-CoV-2 Envelope (NT)
Anti-SARS-CoV-2 Envelope (NT)
Product No.: S537
- -
- -
Target SARS-CoV-2 Product Type Polyclonal Antibody Alternate Names SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Envelope protein, E protein Isotype IgG Applications ELISA |
Data
Direct ELISA - -
- -
Antibody DetailsProduct DetailsReactive Species Virus Host Species Rabbit Immunogen Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein. The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope. Product Concentration 1.0 mg/ml Formulation This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative. Storage and Handling This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient RRIDAB_2831775 Applications and Recommended Usage? Quality Tested by Leinco ELISA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Rabbit Anti-SARS-CoV-2 E recognizes SARS-CoV-2 E. This polyclonal antibody was purified using affinity chromatography. Background A coronavirus, SARS-CoV-2, was first identified in 2019 (COVID-19). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS-CoV-2 can be mediated by the binding of the viral spike protein, a glycosylated protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. PubMed NCBI Gene Bank ID Research Area COVID-19 . Infectious Disease . Seasonal and Respiratory Infections . Viral . IVD Raw Material References & Citations1. Gorbalenya. bioRxiv: (2020).
2. Hui et al. Int J Infect Dis. (2020);91:264-266.
3. Pervushin et al. PLoS Pathog. (2009); 5(7): e1000511. Technical Protocols Certificate of Analysis |
Related Products
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
